I

Ipsen Global

Global biopharma focused on specialty care

Global Patient Safety Senior Scientist - Rare Diseases

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A bioscience degree such as a Bachelor of Science, Bachelor of Arts, Doctor of Pharmacy, master's degree, or PhD.
  • Extensive pharmacovigilance experience within the pharmaceutical industry.
  • Working knowledge of worldwide pharmacovigilance legislation.
  • Prior experience with New Drug Application, Biologics License Application, or equivalent regulatory submissions, or experience reviewing submission files within a regulatory agency.
  • Industry experience in clinical development.
  • Knowledge of product development processes.
  • Fluency in English.

Responsibilities

  • Represent Global Patient Safety within Global Asset and Clinical Development Teams as the key contact for product safety matters.
  • Ensure robust safety surveillance and integrated safety assessments to support timely updates to safety profiles and risk-management actions.
  • Manage safety profiles across development and marketed products so safety informs decision-making and milestones are achieved.
  • Contribute high-quality input to benefit–risk evaluations and collaborate with assigned Safety teams.
  • Provide scientific review and interpretation of safety data for aggregate reports.
  • Conduct signal detection, signal evaluation, risk assessment, and development and management of Risk Management Plans.
  • Work cross-functionally to meet Clinical, Franchise, Asset Team, and Regulatory objectives and ensure reports are submitted according to international regulatory requirements and company timelines.
  • Interpret, analyze, and present scientific and medical data verbally and in writing.
  • Provide scientific expertise for responses to internal and external questions about allocated products and manage and monitor external vendors authoring related documents.
  • Review clinical-trial documentation efficiently and on time.
  • Provide regular safety-data reports, including scientific data analysis, to support medical monitoring.
  • Review clinical-trial safety data throughout clinical development, escalate medical issues, and ensure data meet regulatory quality standards.
  • Provide an overview of pharmacovigilance definitions and Standard Operating Procedures to study investigators and site monitors at study start-up and during trials, supporting timely and accurate serious adverse event reporting.
  • Liaise with Global Drug Development contract research organizations to reconcile serious adverse event data in clinical and Global Patient Safety databases.
  • Liaise with Global Patient Safety contract research organization staff regarding data-processing responsibilities, safety data-handling plans, documentation, and serious adverse event reporting timelines.
  • Ensure timely delivery of accurate information in Development Safety Update Reports and Suspected Unexpected Serious Adverse Reactions to investigators and Ethics Committees, including periodic line listings.
  • Monitor changes to regulatory guidance, requirements, and pharmacovigilance processes and recommend improvements to maintain compliance.
  • Review, update, and implement pharmacovigilance procedures documented in Standard Operating Procedures, guidelines, and user manuals.
  • Collaborate with manufacturing and the Quality Safety Evaluation Board.
  • Provide Global Patient Safety input on medical devices and digital media when applicable.
  • Provide Global Patient Safety input on Patient Data Collection Systems.
  • Lead a team of safety physicians and safety scientists for assigned products as Safety Asset Lead when required.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs